Efficacy of trastuzumab emtansine in patients with HER2 amplified or HER2 over expressed advanced lung, bladder, endometrial and other cancers/tumors.

Trial Profile

Efficacy of trastuzumab emtansine in patients with HER2 amplified or HER2 over expressed advanced lung, bladder, endometrial and other cancers/tumors.

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Dec 2015

At a glance

  • Drugs Trastuzumab emtansine (Primary)
  • Indications Bladder cancer; Endometrial cancer; Lung cancer; Solid tumours
  • Focus Therapeutic Use
  • Acronyms Basket trial
  • Most Recent Events

    • 28 Dec 2015 New trial record
    • 22 Apr 2015 Trial design presented at the 106th Annual Meeting of the American Association for Cancer Research
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top